Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

Beauchet, Olivier; Launay, Cyrille P; Allali, Gilles; Herrmann, François; Annweiler, Cedric

doi:10.1007/s40266-014-0175-3

Scientific article

English

Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

ContributorsBeauchet, Olivier; Launay, Cyrille P; Allali, Gilles; Herrmann, François; Annweiler, Cedric

Published inDrugs & aging, vol. 31, no. 5, p. 363-372

Publication date2014

Abstract

No comparison of anti-dementia drugs-related gait changes has been previously conducted combining single and dual task assessments.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de réadaptation et gériatrie

Research groups

Citation (ISO format)

BEAUCHET, Olivier et al. Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer’s disease. In: Drugs & aging, 2014, vol. 31, n° 5, p. 363–372. doi: 10.1007/s40266-014-0175-3

Article (Published version)

Identifiers

PID : unige:40214
DOI : 10.1007/s40266-014-0175-3
PMID : 24683126

Journal ISSN1170-229X

635views

2downloads

Creation21/07/2014 09:33:00

First validation21/07/2014 09:33:00

Update14/03/2023 21:45:51

Status update14/03/2023 21:45:51

Last indexation30/10/2024 20:02:34

Archive ouverte UNIGE

Gait changes with anti-dementia drugs: a prospective, open-label study combining single and dual task assessments in patients with Alzheimer's disease

No comparison of anti-dementia drugs-related gait changes has been previously conducted combining single and dual task assessments.

Technical informations